Bogart Wealth LLC’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bogart Wealth LLC’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$528	–	1555
2025 Q1	$528	Buy	+4	New	+$498	﹤0.01%	1260

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bogart Wealth LLC's ITCI Position: Q2 2025 in Review

Bogart Wealth LLC sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 4 shares — an estimated $528 sold.

Bogart Wealth LLC first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $528 in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Bogart Wealth LLC reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Bogart Wealth LLC sold 4 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $528.
Bogart Wealth LLC first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Bogart Wealth LLC's Intra-Cellular Therapies Inc. position peaked at $528 in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Bogart Wealth LLC's 13F filing for Q2 2025, filed 30 Jul 2025.